NL7209839A - - Google Patents

Info

Publication number
NL7209839A
NL7209839A NL7209839A NL7209839A NL7209839A NL 7209839 A NL7209839 A NL 7209839A NL 7209839 A NL7209839 A NL 7209839A NL 7209839 A NL7209839 A NL 7209839A NL 7209839 A NL7209839 A NL 7209839A
Authority
NL
Netherlands
Application number
NL7209839A
Other versions
NL175618B (nl
NL175618C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NLAANVRAGE7209839,A priority Critical patent/NL175618C/xx
Priority to GB3213473A priority patent/GB1439225A/en
Priority to US00377978A priority patent/US3853838A/en
Priority to ZA734648A priority patent/ZA734648B/xx
Priority to CA176,197A priority patent/CA1019723A/en
Priority to AU57983/73A priority patent/AU471401B2/en
Priority to CH1025473A priority patent/CH605674A5/xx
Priority to DE2335826A priority patent/DE2335826C2/de
Priority to FR7325905A priority patent/FR2192838B1/fr
Priority to HUAO372A priority patent/HU169437B/hu
Priority to SE7309861A priority patent/SE392721B/xx
Priority to BE133475A priority patent/BE802335A/xx
Priority to JP48079221A priority patent/JPS5936611B2/ja
Publication of NL7209839A publication Critical patent/NL7209839A/xx
Publication of NL175618B publication Critical patent/NL175618B/xx
Application granted granted Critical
Publication of NL175618C publication Critical patent/NL175618C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • C07K14/6955Corticotropin [ACTH] with at least 1 amino acid in D-form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1027Tetrapeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NLAANVRAGE7209839,A 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden. NL175618C (nl)

Priority Applications (13)

Application Number Priority Date Filing Date Title
NLAANVRAGE7209839,A NL175618C (nl) 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.
GB3213473A GB1439225A (en) 1972-07-15 1973-07-05 Sedative peptides
US00377978A US3853838A (en) 1972-07-15 1973-07-10 Sedative peptides related to acth containing a d-phe moiety
ZA734648A ZA734648B (en) 1972-07-15 1973-07-10 Sedative peptides
AU57983/73A AU471401B2 (en) 1972-07-15 1973-07-11 Sedative peptides
CA176,197A CA1019723A (en) 1972-07-15 1973-07-11 Sedative peptides
CH1025473A CH605674A5 (US06262066-20010717-C00315.png) 1972-07-15 1973-07-13
DE2335826A DE2335826C2 (de) 1972-07-15 1973-07-13 Peptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel
FR7325905A FR2192838B1 (US06262066-20010717-C00315.png) 1972-07-15 1973-07-13
HUAO372A HU169437B (US06262066-20010717-C00315.png) 1972-07-15 1973-07-13
SE7309861A SE392721B (sv) 1972-07-15 1973-07-13 Forfarande for framstellning av peptider med psykofarmakologiska egenskaper
BE133475A BE802335A (fr) 1972-07-15 1973-07-13 Nouveau peptide et son procede de preparation
JP48079221A JPS5936611B2 (ja) 1972-07-15 1973-07-13 ペプチドの製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7209839,A NL175618C (nl) 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.

Publications (3)

Publication Number Publication Date
NL7209839A true NL7209839A (US06262066-20010717-C00315.png) 1974-01-17
NL175618B NL175618B (nl) 1984-07-02
NL175618C NL175618C (nl) 1984-12-03

Family

ID=19816526

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7209839,A NL175618C (nl) 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.

Country Status (13)

Country Link
US (1) US3853838A (US06262066-20010717-C00315.png)
JP (1) JPS5936611B2 (US06262066-20010717-C00315.png)
AU (1) AU471401B2 (US06262066-20010717-C00315.png)
BE (1) BE802335A (US06262066-20010717-C00315.png)
CA (1) CA1019723A (US06262066-20010717-C00315.png)
CH (1) CH605674A5 (US06262066-20010717-C00315.png)
DE (1) DE2335826C2 (US06262066-20010717-C00315.png)
FR (1) FR2192838B1 (US06262066-20010717-C00315.png)
GB (1) GB1439225A (US06262066-20010717-C00315.png)
HU (1) HU169437B (US06262066-20010717-C00315.png)
NL (1) NL175618C (US06262066-20010717-C00315.png)
SE (1) SE392721B (US06262066-20010717-C00315.png)
ZA (1) ZA734648B (US06262066-20010717-C00315.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607683A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4144228A (en) * 1976-05-07 1979-03-13 G. D. Searle & Co. Methionine5 -enkephalin sulfoxides and sulfones
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20130059914A1 (en) * 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278010A (US06262066-20010717-C00315.png) * 1961-05-04 1900-01-01
NL6509727A (US06262066-20010717-C00315.png) * 1965-07-28 1967-01-30
GB1230472A (US06262066-20010717-C00315.png) * 1967-07-10 1971-05-05

Also Published As

Publication number Publication date
AU471401B2 (en) 1976-04-29
FR2192838A1 (US06262066-20010717-C00315.png) 1974-02-15
SE392721B (sv) 1977-04-18
JPS5936611B2 (ja) 1984-09-05
NL175618B (nl) 1984-07-02
BE802335A (fr) 1974-01-14
CA1019723A (en) 1977-10-25
US3853838A (en) 1974-12-10
AU5798373A (en) 1975-01-16
JPS4951278A (US06262066-20010717-C00315.png) 1974-05-18
CH605674A5 (US06262066-20010717-C00315.png) 1978-10-13
DE2335826A1 (de) 1974-01-31
ZA734648B (en) 1974-06-26
DE2335826C2 (de) 1984-01-05
HU169437B (US06262066-20010717-C00315.png) 1976-11-28
FR2192838B1 (US06262066-20010717-C00315.png) 1977-01-28
NL175618C (nl) 1984-12-03
GB1439225A (en) 1976-06-16

Similar Documents

Publication Publication Date Title
JPS4978610A (US06262066-20010717-C00315.png)
CS157575B1 (US06262066-20010717-C00315.png)
CS158828B1 (US06262066-20010717-C00315.png)
CS157372B1 (US06262066-20010717-C00315.png)
CS159499B1 (US06262066-20010717-C00315.png)
CS157351B1 (US06262066-20010717-C00315.png)
CS158470B1 (US06262066-20010717-C00315.png)
CS157993B1 (US06262066-20010717-C00315.png)
CS156988B1 (US06262066-20010717-C00315.png)
CS160385B1 (US06262066-20010717-C00315.png)
JPS4956908U (US06262066-20010717-C00315.png)
CS159690B1 (US06262066-20010717-C00315.png)
CS159520B1 (US06262066-20010717-C00315.png)
CS156978B1 (US06262066-20010717-C00315.png)
CS156936B1 (US06262066-20010717-C00315.png)
CS155030B1 (US06262066-20010717-C00315.png)
CS153959B1 (US06262066-20010717-C00315.png)
CS153905B1 (US06262066-20010717-C00315.png)
CH566525A5 (US06262066-20010717-C00315.png)
CH570921A5 (US06262066-20010717-C00315.png)
CH576935A5 (US06262066-20010717-C00315.png)
CH577017A5 (US06262066-20010717-C00315.png)
CH579014A5 (US06262066-20010717-C00315.png)
CH581117A5 (US06262066-20010717-C00315.png)
CH582660A5 (US06262066-20010717-C00315.png)

Legal Events

Date Code Title Description
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee